Guide

Stahls Essential Psychopharmacology
Prescribers
Guide
FIFTH EDITION
With the range of psychotropic drugs expanding and the usages of existing medications
diversifying, we are pleased to present this very latest edition of what has become the
indispensable formulary in psychopharmacology.
This new edition features 16 added new drugs, including six fresh-to-market critical new
compounds, and several older drugs for which there are proven and useful applications.
In addition, many important new indications are covered for existing drugs, as are
updates to the profiles of the entire content and collection.
With its easy-to-use, template-driven navigation system, the Prescribers Guide combines
evidence-based data with clinically informed advice to support everyone prescribing in the
field of mental health.
Stephen M. Stahl is Adjunct Professor of Psychiatry at the University of California, San
Diego, and Honorary Visiting Senior Fellow in Psychiatry at the University of Cambridge,
UK. He has conducted various research projects awarded by the National Institute of
Mental Health, Veterans Affairs, and the pharmaceutical industry. Author of more than
500 articles and chapters, Dr Stahl is also the author of the bestseller Stahls Essential
Psychopharmacology.
Stahls Essential Psychopharmacology
Prescribers
Guide
FIFTH EDITION
Stephen M. Stahl
University of California at San Diego,
San Diego, California
Editorial assistant
Meghan M. Grady
With illustrations by
Nancy Muntner
TRANYLCYPROMINE
THERAPEUTICS
Brands t1BSOBUF
see index for additional brand names
Generic? :FT
t'PSTFDPOEBOETVCTFRVFOUFQJTPEFTPG
EFQSFTTJPO USFBUNFOUNBZOFFEUPCF
JOEFmOJUF
t6TFJOBOYJFUZEJTPSEFSTNBZBMTPOFFEUP
CFJOEFmOJUF
If It Doesnt Work
Class
t.POPBNJOFPYJEBTFJOIJCJUPS ."0*
Commonly Prescribed for
(bold for FDA approved)

tMajor depressive episode without
melancholia
t5SFBUNFOUSFTJTUBOUEFQSFTTJPO
t5SFBUNFOUSFTJTUBOUQBOJDEJTPSEFS
t5SFBUNFOUSFTJTUBOUTPDJBMBOYJFUZEJTPSEFS
How the Drug Works
t*SSFWFSTJCMZCMPDLTNPOPBNJOFPYJEBTF
."0
GSPNCSFBLJOHEPXOOPSFQJOFQISJOF
TFSPUPOJO BOEEPQBNJOF
t5IJTQSFTVNBCMZCPPTUTOPSBESFOFSHJD
TFSPUPOFSHJD BOEEPQBNJOFSHJD
OFVSPUSBOTNJTTJPO
>"TUIFESVHJTTUSVDUVSBMMZSFMBUFEUP
BNQIFUBNJOF JUNBZIBWFTPNFTUJNVMBOU
MJLFBDUJPOTEVFUPNPOPBNJOFSFMFBTFBOE
SFVQUBLFJOIJCJUJPO
How Long Until It Works
t4PNFQBUJFOUTNBZFYQFSJFODFTUJNVMBOU
MJLFBDUJPOTFBSMZJOEPTJOH
t0OTFUPGUIFSBQFVUJDBDUJPOTVTVBMMZOPU
JNNFEJBUF CVUPGUFOEFMBZFEoXFFLT
t*GJUJTOPUXPSLJOHXJUIJOoXFFLT JU
NBZSFRVJSFBEPTBHFJODSFBTFPSJUNBZ
OPUXPSLBUBMM
t.BZDPOUJOVFUPXPSLGPSNBOZZFBSTUP
QSFWFOUSFMBQTFPGTZNQUPNT
If It Works
t5IFHPBMPGUSFBUNFOUJTDPNQMFUF
SFNJTTJPOPGDVSSFOUTZNQUPNTBTXFMMBT
QSFWFOUJPOPGGVUVSFSFMBQTFT
t5SFBUNFOUNPTUPGUFOSFEVDFTPSFWFO
FMJNJOBUFTTZNQUPNT CVUOPUBDVSF
TJODFTZNQUPNTDBOSFDVSBGUFSNFEJDJOF
TUPQQFE
t$POUJOVFUSFBUNFOUVOUJMBMMTZNQUPNTBSF
HPOF SFNJTTJPO
t0ODFTZNQUPNTHPOF DPOUJOVFUSFBUJOHGPS
ZFBSGPSUIFmSTUFQJTPEFPGEFQSFTTJPO
t.BOZQBUJFOUTIBWFPOMZBQBSUJBMSFTQPOTF
XIFSFTPNFTZNQUPNTBSFJNQSPWFECVU
PUIFSTQFSTJTU FTQFDJBMMZJOTPNOJB GBUJHVF
BOEQSPCMFNTDPODFOUSBUJOH
t0UIFSQBUJFOUTNBZCFOPOSFTQPOEFST
TPNFUJNFTDBMMFEUSFBUNFOUSFTJTUBOUPS
USFBUNFOUSFGSBDUPSZ
t4PNFQBUJFOUTXIPIBWFBOJOJUJBMSFTQPOTF
NBZSFMBQTFFWFOUIPVHIUIFZDPOUJOVF
USFBUNFOU TPNFUJNFTDBMMFEiQPPQPVUw
t$POTJEFSJODSFBTJOHEPTF TXJUDIJOHUP
BOPUIFSBHFOU PSBEEJOHBOBQQSPQSJBUF
BVHNFOUJOHBHFOU
t$POTJEFSQTZDIPUIFSBQZ
t$POTJEFSFWBMVBUJPOGPSBOPUIFSEJBHOPTJT
PSGPSBDPNPSCJEDPOEJUJPO FH NFEJDBM
JMMOFTT TVCTUBODFBCVTF FUD
t4PNFQBUJFOUTNBZFYQFSJFODFBQQBSFOU
MBDLPGDPOTJTUFOUFGmDBDZEVFUPBDUJWBUJPO
PGMBUFOUPSVOEFSMZJOHCJQPMBSEJTPSEFS BOE
SFRVJSFBOUJEFQSFTTBOUEJTDPOUJOVBUJPOBOE
BTXJUDIUPBNPPETUBCJMJ[FS
Best Augmenting Combos

for Partial Response or
Treatment Resistance
>"VHNFOUBUJPOPG."0*TIBTOPU
CFFOTZTUFNBUJDBMMZTUVEJFE BOEUIJTJT
TPNFUIJOHGPSUIFFYQFSU UPCFEPOFXJUI
DBVUJPOBOEXJUIDBSFGVMNPOJUPSJOH
>"TUJNVMBOUTVDIBTEBNQIFUBNJOF
PSNFUIZMQIFOJEBUF XJUIDBVUJPONBZ
BDUJWBUFCJQPMBSEJTPSEFSBOETVJDJEBM
JEFBUJPONBZFMFWBUFCMPPEQSFTTVSF
t-JUIJVN
t.PPETUBCJMJ[JOHBOUJDPOWVMTBOUT
t"UZQJDBMBOUJQTZDIPUJDT XJUITQFDJBM
DBVUJPOGPSUIPTFBHFOUTXJUINPOPBNJOF
SFVQUBLFCMPDLJOHQSPQFSUJFT TVDIBT
[JQSBTJEPOFBOE[PUFQJOF
Tests
t1BUJFOUTTIPVMECFNPOJUPSFEGPSDIBOHFT
JOCMPPEQSFTTVSF
t1BUJFOUTSFDFJWJOHIJHIEPTFTPSMPOHUFSN
USFBUNFOUTIPVMEIBWFIFQBUJDGVODUJPO
FWBMVBUFEQFSJPEJDBMMZ
675
TRANYLCYPROMINE DPOUJOVFE
SIDE EFFECTS
How Drug Causes Side Effects
t5IFPSFUJDBMMZEVFUPJODSFBTFTJO
NPOPBNJOFTJOQBSUTPGUIFCSBJOBOECPEZ
BOEBUSFDFQUPSTPUIFSUIBOUIPTFUIBU
DBVTFUIFSBQFVUJDBDUJPOT FH VOXBOUFE
BDUJPOTPGTFSPUPOJOJOTMFFQDFOUFST
DBVTJOHJOTPNOJB VOXBOUFEBDUJPOTPG
OPSFQJOFQISJOFPOWBTDVMBSTNPPUINVTDMF
DBVTJOHIZQFSUFOTJPO FUD
t4JEFFGGFDUTBSFHFOFSBMMZJNNFEJBUF CVU
JNNFEJBUFTJEFFGGFDUTPGUFOEJTBQQFBSJO
UJNF
Notable Side Effects
t"HJUBUJPO BOYJFUZ JOTPNOJB XFBLOFTT

TFEBUJPO EJ[[JOFTT
t$POTUJQBUJPO ESZNPVUI OBVTFB EJBSSIFB
DIBOHFJOBQQFUJUF XFJHIUHBJO
t4FYVBMEZTGVODUJPO
t0SUIPTUBUJDIZQPUFOTJPO EPTFSFMBUFE

TZODPQFNBZEFWFMPQBUIJHIEPTFT
Life-Threatening or
Dangerous Side Effects
t)ZQFSUFOTJWFDSJTJT FTQFDJBMMZXIFO."0*T
BSFVTFEXJUIDFSUBJOUZSBNJOFDPOUBJOJOH
GPPETPSQSPIJCJUFEESVHT
t*OEVDUJPOPGNBOJB
t3BSFBDUJWBUJPOPGTVJDJEBMJEFBUJPOBOE
CFIBWJPS TVJDJEBMJUZ
TIPSUUFSNTUVEJFT
EJEOPUTIPXBOJODSFBTFJOUIFSJTLPG
TVJDJEBMJUZXJUIBOUJEFQSFTTBOUTDPNQBSFE
UPQMBDFCPCFZPOEBHF
t4FJ[VSFT
t)FQBUPUPYJDJUZ
Weight Gain
t5BLFBUOJHIUJGEBZUJNFTFEBUJPOUBLFJO
EBZUJNFJGPWFSTUJNVMBUFEBUOJHIU
t4XJUDIBGUFSBQQSPQSJBUFXBTIPVUUPBO
443*PSOFXFSBOUJEFQSFTTBOU
Best Augmenting Agents for Side

Effects
t5SB[PEPOF XJUIDBVUJPO
GPSJOTPNOJB
t#FO[PEJB[FQJOFTGPSJOTPNOJB
>4JOHMFPSBMPSTVCMJOHVBMEPTFPGB
DBMDJVNDIBOOFMCMPDLFS FH OJGFEJQJOF

GPSVSHFOUUSFBUNFOUPGIZQFSUFOTJPOEVFUP
ESVHJOUFSBDUJPOPSEJFUBSZUZSBNJOF
t.BOZTJEFFGGFDUTDBOOPUCFJNQSPWFEXJUI
BOBVHNFOUJOHBHFOU
DOSING AND USE

Usual Dosage Range
tNHEBZJOEJWJEFEEPTFT
Dosage Forms
t5BCMFUNH
How to Dose
t*OJUJBMNHEBZJOEJWJEFEEPTFTBGUFS
XFFLTJODSFBTFCZNHEBZFBDI
oXFFLTNBYJNVNNHEBZ
Dosing Tips
t0SUIPTUBUJDIZQPUFOTJPO FTQFDJBMMZBUIJHI
EPTFT NBZSFRVJSFTQMJUUJOHJOUPoEBJMZ
EPTFT
t1BUJFOUTSFDFJWJOHIJHIEPTFTNBZOFFE
UPCFFWBMVBUFEQFSJPEJDBMMZGPSFGGFDUTPO
UIFMJWFS
Overdose
Sedation
t%J[[JOFTT TFEBUJPO BUBYJB IFBEBDIF

JOTPNOJB SFTUMFTTOFTT BOYJFUZ JSSJUBCJMJUZ
DBSEJPWBTDVMBSFGGFDUT DPOGVTJPO
SFTQJSBUPSZEFQSFTTJPO PSDPNBNBZBMTP
PDDVS
t.BOZFYQFSJFODFBOEPSDBOCFTJHOJmDBOU
JOBNPVOU
t$BOBMTPDBVTFBDUJWBUJPO
Long-Term Use
t0DDVSTJOTJHOJmDBOUNJOPSJUZ
What to Do About Side Effects
t8BJU
t8BJU
t8BJU
t-PXFSUIFEPTF
676
t.BZSFRVJSFQFSJPEJDFWBMVBUJPOPGIFQBUJD
GVODUJPO
t."0*TNBZMPTFFGmDBDZMPOHUFSN
Habit Forming
t4PNFQBUJFOUTIBWFEFWFMPQFEEFQFOEFODF
UP."0*T
DPOUJOVFE
How to Stop
t(FOFSBMMZOPOFFEUPUBQFS BTUIFESVH
XFBSTPGGTMPXMZPWFSoXFFLT
Pharmacokinetics
t$MJOJDBMEVSBUJPOPGBDUJPONBZCFVQUP
EBZTEVFUPJSSFWFSTJCMFFO[ZNFJOIJCJUJPO
Drug Interactions
t5SBNBEPMNBZJODSFBTFUIFSJTLPGTFJ[VSFT
JOQBUJFOUTUBLJOHBO."0JOIJCJUPS
t$BODBVTFBGBUBMiTFSPUPOJOTZOESPNFw
XIFODPNCJOFEXJUIESVHTUIBUCMPDL
TFSPUPOJOSFVQUBLF TPEPOPUVTFXJUIB
TFSPUPOJOSFVQUBLFJOIJCJUPSPSGPSIBMG
MJWFTBGUFSTUPQQJOHUIFTFSPUPOJOSFVQUBLF
JOIJCJUPS TFF5BCMFBGUFS1FBSMT
t)ZQFSUFOTJWFDSJTJTXJUIIFBEBDIF
JOUSBDSBOJBMCMFFEJOH BOEEFBUINBZ
SFTVMUGSPNDPNCJOJOH."0JOIJCJUPST
XJUITZNQBUIPNJNFUJDESVHT FH
BNQIFUBNJOFT NFUIZMQIFOJEBUF DPDBJOF
EPQBNJOF FQJOFQISJOF OPSFQJOFQISJOF
BOESFMBUFEDPNQPVOETNFUIZMEPQB
MFWPEPQB LUSZQUPQIBO LUZSPTJOF BOE
QIFOZMBMBOJOF
t%POPUDPNCJOFXJUIBOPUIFS."0
JOIJCJUPS BMDPIPM PSHVBOFUIJEJOF
t"EWFSTFESVHSFBDUJPOTDBOSFTVMUGSPN
DPNCJOJOH."0JOIJCJUPSTXJUIUSJDZDMJD
UFUSBDZDMJDBOUJEFQSFTTBOUTBOESFMBUFE
DPNQPVOET JODMVEJOHDBSCBNB[FQJOF
DZDMPCFO[BQSJOF BOENJSUB[BQJOF BOE
TIPVMECFBWPJEFEFYDFQUCZFYQFSUTUP
USFBUEJGmDVMUDBTFT
t."0JOIJCJUPSTJODPNCJOBUJPOXJUI
TQJOBMBOFTUIFTJBNBZDBVTFDPNCJOFE
IZQPUFOTJWFFGGFDUT
t$PNCJOBUJPOPG."0*TBOE$/4
EFQSFTTBOUTNBZFOIBODFTFEBUJPOBOE
IZQPUFOTJPO
Other Warnings/
Precautions
t6TFSFRVJSFTMPXUZSBNJOFEJFU TFF5BCMF
BGUFS1FBSMT
t1BUJFOUBOEQSFTDSJCFSNVTUCFWJHJMBOU
UPQPUFOUJBMJOUFSBDUJPOTXJUIBOZESVH
JODMVEJOHBOUJIZQFSUFOTJWFTBOEPWFSUIF
DPVOUFSDPVHIDPMEQSFQBSBUJPOT
t0WFSUIFDPVOUFSNFEJDBUJPOT
UPBWPJEJODMVEFDPVHIBOEDPME
QSFQBSBUJPOT JODMVEJOHUIPTFDPOUBJOJOH
TRANYLCYPROMINE
EFYUSPNFUIPSQIBO OBTBMEFDPOHFTUBOUT
UBCMFUT ESPQT PSTQSBZ
IBZGFWFS
NFEJDBUJPOT TJOVTNFEJDBUJPOT BTUINB
JOIBMBOUNFEJDBUJPOT BOUJBQQFUJUF
NFEJDBUJPOT XFJHIUSFEVDJOHQSFQBSBUJPOT
iQFQwQJMMT TFF5BCMFBGUFS1FBSMT
t)ZQPHMZDFNJBNBZPDDVSJOEJBCFUJD
QBUJFOUTSFDFJWJOHJOTVMJOPSPSBM
BOUJEJBCFUJDBHFOUT
t6TFDBVUJPVTMZJOQBUJFOUTSFDFJWJOH
SFTFSQJOF BOFTUIFUJDT EJTVMmSBN
NFUSJ[BNJEF BOUJDIPMJOFSHJDBHFOUT
t5SBOZMDZQSPNJOFJTOPUSFDPNNFOEFEGPS
VTFJOQBUJFOUTXIPDBOOPUCFNPOJUPSFE
DMPTFMZ
t8IFOUSFBUJOHDIJMESFO DBSFGVMMZXFJHI
UIFSJTLTBOECFOFmUTPGQIBSNBDPMPHJDBM
USFBUNFOUBHBJOTUUIFSJTLTBOECFOFmUT
PGOPOUSFBUNFOUXJUIBOUJEFQSFTTBOUTBOE
NBLFTVSFUPEPDVNFOUUIJTJOUIFQBUJFOUT
DIBSU
t%JTUSJCVUFUIFCSPDIVSFTQSPWJEFECZUIF
'%"BOEUIFESVHDPNQBOJFT
t8BSOQBUJFOUTBOEUIFJSDBSFHJWFSTBCPVU
UIFQPTTJCJMJUZPGBDUJWBUJOHTJEFFGGFDUT
BOEBEWJTFUIFNUPSFQPSUTVDITZNQUPNT
JNNFEJBUFMZ
t.POJUPSQBUJFOUTGPSBDUJWBUJPOPG
TVJDJEBMJEFBUJPO FTQFDJBMMZDIJMESFOBOE
BEPMFTDFOUT
Do Not Use
t*GQBUJFOUJTUBLJOHNFQFSJEJOF QFUIJEJOF
t*GQBUJFOUJTUBLJOHBTZNQBUIPNJNFUJD
BHFOUPSUBLJOHHVBOFUIJEJOF
t*GQBUJFOUJTUBLJOHBOPUIFS."0*
t*GQBUJFOUJTUBLJOHBOZBHFOUUIBUDBO
JOIJCJUTFSPUPOJOSFVQUBLF FH 443*T
TJCVUSBNJOF USBNBEPM NJMOBDJQSBO
EVMPYFUJOF WFOMBGBYJOF DMPNJQSBNJOF FUD
t*GQBUJFOUJTUBLJOHEJVSFUJDT
EFYUSPNFUIPSQIBO
t*GQBUJFOUIBTQIFPDISPNPDZUPNB
t*GQBUJFOUIBTDBSEJPWBTDVMBSPS
DFSFCSPWBTDVMBSEJTFBTF
t*GQBUJFOUIBTGSFRVFOUPSTFWFSFIFBEBDIFT
t*GQBUJFOUJTVOEFSHPJOHFMFDUJWFTVSHFSZ
BOESFRVJSFTHFOFSBMBOFTUIFTJB
t*GQBUJFOUIBTBIJTUPSZPGMJWFSEJTFBTFPS
BCOPSNBMMJWFSGVODUJPOUFTUT
t*GQBUJFOUJTUBLJOHBQSPIJCJUFEESVH
t*GQBUJFOUJTOPUDPNQMJBOUXJUIBMPX
UZSBNJOFEJFU
t*GUIFSFJTBQSPWFOBMMFSHZUP
USBOZMDZQSPNJOF
677
SPECIAL POPULATIONS
Renal Impairment
t6TFXJUIDBVUJPOoESVHNBZBDDVNVMBUF
JOQMBTNB
t.BZSFRVJSFMPXFSUIBOVTVBMBEVMUEPTF
Hepatic Impairment
t5SBOZMDZQSPNJOFTIPVMEOPUCFVTFEJO
QBUJFOUTXJUIIJTUPSZPGIFQBUJDJNQBJSNFOU
PSJOQBUJFOUTXJUIBCOPSNBMMJWFSGVODUJPO
UFTUT
Cardiac Impairment
Breast Feeding
t4PNFESVHJTGPVOEJONPUIFSTCSFBTUNJML
t&GGFDUTPOJOGBOUVOLOPXO
t*NNFEJBUFQPTUQBSUVNQFSJPEJTBIJHISJTL
UJNFGPSEFQSFTTJPO FTQFDJBMMZJOXPNFO
XIPIBWFIBEQSJPSEFQSFTTJWFFQJTPEFT
TPESVHNBZOFFEUPCFSFJOTUJUVUFEMBUF
JOUIFUIJSEUSJNFTUFSPSTIPSUMZBGUFS
DIJMECJSUIUPQSFWFOUBSFDVSSFODFEVSJOH
UIFQPTUQBSUVNQFSJPE
t4IPVMEFWBMVBUFQBUJFOUGPSUSFBUNFOUXJUI
BOBOUJEFQSFTTBOUXJUIBCFUUFSSJTLCFOFmU
SBUJP
t$POUSBJOEJDBUFEJOQBUJFOUTXJUIBOZDBSEJBD
JNQBJSNFOU
Elderly
t*OJUJBMEPTFMPXFSUIBOVTVBMBEVMUEPTF
t&MEFSMZQBUJFOUTNBZIBWFHSFBUFS
TFOTJUJWJUZUPBEWFSTFFGGFDUT
t3FEVDUJPOJOUIFSJTLPGTVJDJEBMJUZXJUI
BOUJEFQSFTTBOUTDPNQBSFEUPQMBDFCPJO
BEVMUTBHFBOEPMEFS
THE ART OF PSYCHOPHARMACOLOGY
Children and Adolescents
t3FRVJSFTDPNQMJBODFUPEJFUBSZSFTUSJDUJPOT
DPODPNJUBOUESVHSFTUSJDUJPOT
t1BUJFOUTXJUIDBSEJBDQSPCMFNTPS
IZQFSUFOTJPO
t.VMUJQMFEBJMZEPTFT
t/PUHFOFSBMMZSFDPNNFOEFEGPSVTFJO
DIJMESFOVOEFSBHF
t$BSFGVMMZXFJHIUIFSJTLTBOECFOFmUT
PGQIBSNBDPMPHJDBMUSFBUNFOUBHBJOTU
UIFSJTLTBOECFOFmUTPGOPOUSFBUNFOU
XJUIBOUJEFQSFTTBOUTBOENBLFTVSFUP
EPDVNFOUUIJTJOUIFQBUJFOUTDIBSU
t.POJUPSQBUJFOUTGBDFUPGBDFSFHVMBSMZ
QBSUJDVMBSMZEVSJOHUIFmSTUTFWFSBMXFFLT
PGUSFBUNFOU
t6TFXJUIDBVUJPO PCTFSWJOHGPSBDUJWBUJPO
PGLOPXOPSVOLOPXOCJQPMBSEJTPSEFSBOE
PSTVJDJEBMJEFBUJPO BOEJOGPSNQBSFOUT
PSHVBSEJBOTPGUIJTSJTLTPUIFZDBOIFMQ
PCTFSWFDIJMEPSBEPMFTDFOUQBUJFOUT
Pregnancy
t3JTL$BUFHPSZ$<TPNFBOJNBMTUVEJFT
TIPXBEWFSTFFGGFDUTOPDPOUSPMMFETUVEJFT
JOIVNBOT>
t/PUHFOFSBMMZSFDPNNFOEFEGPSVTFEVSJOH
QSFHOBODZ FTQFDJBMMZEVSJOHmSTUUSJNFTUFS
t4IPVMEFWBMVBUFQBUJFOUGPSUSFBUNFOUXJUI
BOBOUJEFQSFTTBOUXJUIBCFUUFSSJTLCFOFmU
SBUJP
678
Potential Advantages
t"UZQJDBMEFQSFTTJPO
t4FWFSFEFQSFTTJPO
t5SFBUNFOUSFTJTUBOUEFQSFTTJPOPSBOYJFUZ
EJTPSEFST
Potential Disadvantages
Primary Target Symptoms
t%FQSFTTFENPPE
t4PNBUJDTZNQUPNT
t4MFFQBOEFBUJOHEJTUVSCBODFT
t1TZDIPNPUPSSFUBSEBUJPO
t.PSCJEQSFPDDVQBUJPO
Pearls
t."0*TBSFHFOFSBMMZSFTFSWFEGPS
TFDPOEMJOFVTFBGUFS443*T 4/3*T BOE
DPNCJOBUJPOTPGOFXFSBOUJEFQSFTTBOUT
IBWFGBJMFE
t1BUJFOUTIPVMECFBEWJTFEOPUUPUBLFBOZ
QSFTDSJQUJPOPSPWFSUIFDPVOUFSESVHT
XJUIPVUDPOTVMUJOHUIFJSEPDUPSCFDBVTFPG
QPTTJCMFESVHJOUFSBDUJPOTXJUIUIF."0*
t)FBEBDIFJTPGUFOUIFmSTUTZNQUPNPG
IZQFSUFOTJWFDSJTJT
t5IFSJHJEEJFUBSZSFTUSJDUJPOTNBZSFEVDF
DPNQMJBODF TFF5BCMFBGUFS1FBSMT
DPOUJOVFE
t.PPEEJTPSEFSTDBOCFBTTPDJBUFEXJUI
FBUJOHEJTPSEFST FTQFDJBMMZJOBEPMFTDFOU
GFNBMFT
BOEUSBOZMDZQSPNJOFDBOCFVTFE
UPUSFBUCPUIEFQSFTTJPOBOECVMJNJB
t."0*TBSFBWJBCMFTFDPOEMJOFUSFBUNFOU
PQUJPOJOEFQSFTTJPO CVUBSFOPUGSFRVFOUMZ
VTFE
>.ZUITBCPVUUIFEBOHFSPGEJFUBSZ
UZSBNJOFDBOCFFYBHHFSBUFE CVU
QSPIJCJUJPOTBHBJOTUDPODPNJUBOUESVHT
PGUFOOPUGPMMPXFEDMPTFMZFOPVHI
t0SUIPTUBUJDIZQPUFOTJPO JOTPNOJB BOE
TFYVBMEZTGVODUJPOBSFPGUFOUIFNPTU
USPVCMFTPNFDPNNPOTJEFFGGFDUT
>."0*TTIPVMECFGPSUIFFYQFSU
FTQFDJBMMZJGDPNCJOJOHXJUIBHFOUTPG
QPUFOUJBMSJTL FH TUJNVMBOUT USB[PEPOF
5$"T
>."0*TTIPVMEOPUCFOFHMFDUFEBT
UIFSBQFVUJDBHFOUTGPSUIFUSFBUNFOU
SFTJTUBOU
t"MUIPVHIHFOFSBMMZQSPIJCJUFE BIFSPJD
CVUQPUFOUJBMMZEBOHFSPVTUSFBUNFOUGPS
TFWFSFMZUSFBUNFOUSFTJTUBOUQBUJFOUTJT
GPSBOFYQFSUUPHJWFBUSJDZDMJDUFUSBDZDMJD
TRANYLCYPROMINE
BOUJEFQSFTTBOUPUIFSUIBODMPNJQSBNJOF
TJNVMUBOFPVTMZXJUIBO."0JOIJCJUPSGPS
QBUJFOUTXIPGBJMUPSFTQPOEUPOVNFSPVT
PUIFSBOUJEFQSFTTBOUT
t6TFPG."0*TXJUIDMPNJQSBNJOFJTBMXBZT
QSPIJCJUFECFDBVTFPGUIFSJTLPGTFSPUPOJO
TZOESPNFBOEEFBUI
t"NPYBQJOFNBZCFUIFQSFGFSSFEUSZDZDMJD
UFUSBDZDMJDBOUJEFQSFTTBOUUPDPNCJOF
XJUIBO."0*JOIFSPJDDBTFTEVFUPJUT
UIFPSFUJDBMMZQSPUFDUJWF)5"BOUBHPOJTU
QSPQFSUJFT
t*GUIJTPQUJPOJTFMFDUFE TUBSUUIF."0*
XJUIUIFUSJDZDMJDUFUSBDZDMJDBOUJEFQSFTTBOU
TJNVMUBOFPVTMZBUMPXEPTFTBGUFS
BQQSPQSJBUFESVHXBTIPVU UIFOBMUFSOBUFMZ
JODSFBTFEPTFTPGUIFTFBHFOUTFWFSZGFX
EBZTUPBXFFLBTUPMFSBUFE
t"MUIPVHIWFSZTUSJDUEJFUBSZBOE
DPODPNJUBOUESVHSFTUSJDUJPOTNVTUCF
PCTFSWFEUPQSFWFOUIZQFSUFOTJWFDSJTFT
BOETFSPUPOJOTZOESPNF UIFNPTU
DPNNPOTJEFFGGFDUTPG."0*BOEUSJDZDMJD
UFUSBDZDMJDDPNCJOBUJPOTNBZCFXFJHIU
HBJOBOEPSUIPTUBUJDIZQPUFOTJPO
5BCMF %SVHTDPOUSBJOEJDBUFEEVFUPSJTLPGTFSPUPOJOTZOESPNFUPYJDJUZ
Do Not Use:
Antidepressants
443*T
4/3*T
$MPNJQSBNJOF
4U+PIOTXPSU
Drugs of Abuse
.%." FDTUBTZ
Opioids
.FQFSJEJOF
$PDBJOF
.FUIBNQIFUBNJOF
)JHIEPTF
PSJOKFDUFE
BNQIFUBNJOF
5SBNBEPM
.FUIBEPOF
'FOUBOZM
Other
/POTVCDVUBOFPVT
TVNBUSJQUBO
$IMPSQIFOJSBNJOF
#SPNQIFOJSBNJOF
%FYUSPNFUIPSQIBO
1SPDBSCB[JOF
679
5BCMF %JFUBSZHVJEFMJOFTGPSQBUJFOUTUBLJOH."0*T
Foods to avoid*
Foods allowed
%SJFE BHFE TNPLFE GFSNFOUFE

TQPJMFE PSJNQSPQFSMZTUPSFENFBU
QPVMUSZ BOEmTI
'SFTIPSQSPDFTTFENFBU QPVMUSZ BOEmTI

QSPQFSMZTUPSFEQJDLMFEPSTNPLFEmTI
#SPBECFBOQPET
"MMPUIFSWFHFUBCMFT
"HFEDIFFTFT
1SPDFTTFEDIFFTFTMJDFT DPUUBHFDIFFTF
SJDPUUBDIFFTF ZPHVSU DSFBNDIFFTF
5BQBOEVOQBTUFVSJ[FECFFS
$BOOFEPSCPUUMFECFFSBOEBMDPIPM
.BSNJUF
#SFXFSTBOECBLFSTZFBTU
4BVFSLSBVU LJNDIFF
4PZQSPEVDUTUPGV
1FBOVUT
#BOBOBQFFM
#BOBOBT BWPDBEPT SBTQCFSSJFT
5ZSBNJOFDPOUBJOJOHOVUSJUJPOBM
TVQQMFNFOU
/PUOFDFTTBSZGPSNHUSBOTEFSNBMPSMPXEPTFPSBMTFMFHJMJOF
5BCMF %SVHTUIBUCPPTUOPSFQJOFQISJOFTIPVMEPOMZCFVTFEXJUIDBVUJPOXJUI."0*T
Use With Caution:
Decongestants
Stimulants
Antidepressants
with norepinephrine
reuptake inhibition
Other
1IFOZMFQISJOF
"NQIFUBNJOFT
.PTUUSJDZDMJDT
1IFOUFSNJOF
1TFVEPFQIFESJOF
.FUIZMQIFOJEBUF
/3*T
-PDBMBOFTUIFUJDT
DPOUBJOJOH
WBTPDPOTUSJDUPST
$PDBJOF
/%3*T
.FUIBNQIFUBNJOF
.PEBmOJM
5BQFOUBEPM
"SNPEBmOJM
Suggested Reading
#BLFS(# $PVUUT35 .D,FOOB,'
4IFSSZ.D,FOOB3-*OTJHIUTJOUPUIF
NFDIBOJTNTPGBDUJPOPGUIF."0JOIJCJUPST
QIFOFM[JOFBOEUSBOZMDZQSPNJOFBSFWJFX
+1TZDIJBUSZ/FVSPTDJo
,FOOFEZ4)$POUJOVBUJPOBOENBJOUFOBODF
USFBUNFOUTJONBKPSEFQSFTTJPOUIFOFHMFDUFE
SPMFPGNPOPBNJOFPYJEBTFJOIJCJUPST
+1TZDIJBUSZ/FVSPTDJo
680
-JQQNBO4# /BTI,.POPBNJOFPYJEBTF
JOIJCJUPSVQEBUF1PUFOUJBMBEWFSTFGPPEBOE
ESVHJOUFSBDUJPOT%SVH4BGo
5IBTF.& 5SJZFEJ.) 3VTI"+."0*TJO
UIFDPOUFNQPSBSZUSFBUNFOUPGEFQSFTTJPO
/FVSPQTZDIPQIBSNBDPMPHZo

Guide

Uploaded by

Copyright:

Available Formats

You might also like

Guide

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Guide

Uploaded by

Copyright:

Available Formats

Stahls Essential Psychopharmacology

Stahls Essential Psychopharmacology

see index for additional brand names

Commonly Prescribed for

(bold for FDA approved)

How the Drug Works

How Long Until It Works

Best Augmenting Combos

Notable Side Effects

t"HJUBUJPO BOYJFUZ JOTPNOJB XFBLOFTT

Best Augmenting Agents for Side

DOSING AND USE

t%J[[JOFTT TFEBUJPO BUBYJB IFBEBDIF

What to Do About Side Effects

THE ART OF PSYCHOPHARMACOLOGY

Children and Adolescents

Primary Target Symptoms

%SJFE BHFE TNPLFE GFSNFOUFE

'SFTIPSQSPDFTTFENFBU QPVMUSZ BOEmTI

#BOBOBT BWPDBEPT SBTQCFSSJFT

You might also like

'SFTIPSQSPDFTTFENFBU QPVMUSZ BOEmTI